Booz Allen Hamilton (BAH) Competitors $110.20 +0.88 (+0.80%) As of 11:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, DOX, EPAM, TDC, and HCKTShould you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), Amdocs (DOX), EPAM Systems (EPAM), Teradata (TDC), and The Hackett Group (HCKT). Booz Allen Hamilton vs. Its Competitors Cross Country Healthcare CACI International Leidos Science Applications International Cognizant Technology Solutions Gartner Amdocs EPAM Systems Teradata The Hackett Group Booz Allen Hamilton (NYSE:BAH) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends. Is BAH or CCRN more profitable? Booz Allen Hamilton has a net margin of 8.70% compared to Cross Country Healthcare's net margin of -0.70%. Booz Allen Hamilton's return on equity of 73.05% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Booz Allen Hamilton8.70% 73.05% 11.61% Cross Country Healthcare -0.70%1.72%1.24% Which has preferable earnings & valuation, BAH or CCRN? Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBooz Allen Hamilton$11.98B1.13$935M$8.1413.54Cross Country Healthcare$1.34B0.33-$14.56M-$0.26-51.90 Do insiders & institutionals hold more shares of BAH or CCRN? 91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer BAH or CCRN? In the previous week, Booz Allen Hamilton had 28 more articles in the media than Cross Country Healthcare. MarketBeat recorded 31 mentions for Booz Allen Hamilton and 3 mentions for Cross Country Healthcare. Booz Allen Hamilton's average media sentiment score of 1.37 beat Cross Country Healthcare's score of 0.45 indicating that Booz Allen Hamilton is being referred to more favorably in the media. Company Overall Sentiment Booz Allen Hamilton Positive Cross Country Healthcare Neutral Do analysts rate BAH or CCRN? Booz Allen Hamilton currently has a consensus price target of $134.00, suggesting a potential upside of 21.56%. Cross Country Healthcare has a consensus price target of $17.93, suggesting a potential upside of 32.86%. Given Cross Country Healthcare's higher possible upside, analysts clearly believe Cross Country Healthcare is more favorable than Booz Allen Hamilton.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Booz Allen Hamilton 2 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.25Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk and volatility, BAH or CCRN? Booz Allen Hamilton has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. SummaryBooz Allen Hamilton beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks. Get Booz Allen Hamilton News Delivered to You Automatically Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BAH vs. The Competition Export to ExcelMetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$13.59B$6.73B$22.54B$20.92BDividend Yield2.01%1.76%2.82%3.59%P/E Ratio13.5523.1628.0228.20Price / Sales1.132.5742.0056.73Price / Cash14.1316.4126.1617.81Price / Book13.925.416.424.57Net Income$935M$272.15M$197.80M$993.62M7 Day Performance0.94%1.14%1.64%2.37%1 Month Performance0.89%-6.16%-1.94%1.44%1 Year Performance-25.35%-8.62%28.92%13.74% Booz Allen Hamilton Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BAHBooz Allen Hamilton4.8979 of 5 stars$110.24+0.8%$134.00+21.6%-25.9%$13.59B$11.98B13.5535,800Positive NewsShort Interest ↑Analyst RevisionCCRNCross Country Healthcare3.4199 of 5 stars$12.67-0.4%$17.93+41.5%-8.6%$415.10M$1.19B-48.738,205CACICACI International3.0909 of 5 stars$479.19-3.2%$536.54+12.0%+5.2%$10.54B$8.63B21.4425,000LDOSLeidos4.6389 of 5 stars$177.23+0.4%$179.46+1.3%+20.0%$22.74B$17.05B16.7548,000Positive NewsSAICScience Applications International3.374 of 5 stars$115.87-0.7%$125.64+8.4%-5.9%$5.43B$7.51B19.5426,000Positive NewsCTSHCognizant Technology Solutions4.7879 of 5 stars$69.15-0.6%$86.56+25.2%-7.7%$33.77B$19.74B14.05336,800Positive NewsITGartner4.973 of 5 stars$226.00-1.3%$369.25+63.4%-50.5%$17.39B$6.42B13.9121,044High Trading VolumeDOXAmdocs4.7191 of 5 stars$86.45-3.3%$105.33+21.8%+4.1%$9.76B$4.65B17.5429,058EPAMEPAM Systems4.7914 of 5 stars$151.96-3.8%$231.73+52.5%-21.6%$8.46B$4.73B21.6861,200Positive NewsAnalyst UpgradeGap UpTDCTeradata3.8364 of 5 stars$20.15-1.9%$26.86+33.3%-23.5%$1.90B$1.68B17.835,700Positive NewsHCKTThe Hackett Group4.2515 of 5 stars$20.47-1.0%$29.67+44.9%-20.9%$563.13M$313.86M34.121,478Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Cross Country Healthcare Competitors CACI International Competitors Leidos Competitors Science Applications International Competitors Cognizant Technology Solutions Competitors Gartner Competitors Amdocs Competitors EPAM Systems Competitors Teradata Competitors The Hackett Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BAH) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Booz Allen Hamilton Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Booz Allen Hamilton With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access